Citation 71290

UBUKATA,M: OSADA,H: KUDO,T: ISONO,K:. (1993). RESPINOMYCINS A1, A2 B, C AND D, A NOVEL GROUP OF ANTHRACYCLINE ANTIBIOTICS. I. TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITIES.. 46(6)

Citation Details

Title	RESPINOMYCINS A1, A2 B, C AND D, A NOVEL GROUP OF ANTHRACYCLINE ANTIBIOTICS. I. TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITIES.
Authors	UBUKATA,M: OSADA,H: KUDO,T: ISONO,K:
Year	1993
Volume	46
Issue	6

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces xanthocidicus (STREPTOMYCETACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RESPINOMYCIN A-1	None
2	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN A-1	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESPINOMYCIN A-1	WEAK ACTIVITY
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-1	INACTIVE
5	ANTIPHAGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN A-1	WEAK ACTIVITY
6	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	RESPINOMYCIN A-1	.
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-1	ACTIVE
8	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-1	ACTIVE
9	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-1	INACTIVE
10	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESPINOMYCIN A-2	None
11	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN A-2	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESPINOMYCIN A-2	WEAK ACTIVITY
13	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-2	WEAK ACTIVITY
14	ANTIPHAGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN A-2	STRONG ACTIVITY
15	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	RESPINOMYCIN A-2	INACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-2	INACTIVE
17	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-2	WEAK ACTIVITY
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN A-2	INACTIVE
19	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESPINOMYCIN B	None
20	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN B	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESPINOMYCIN B	WEAK ACTIVITY
22	ANTIMICROBIAL ACTIVITY(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN B	INACTIVE
23	ANTIPHAGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN B	WEAK ACTIVITY
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN B	ACTIVE
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN B	WEAK ACTIVITY
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN B	INACTIVE
27	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESPINOMYCIN C	None
28	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN C	ACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESPINOMYCIN C	WEAK ACTIVITY
30	ANTIMICROBIAL ACTIVITY(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN C	INACTIVE
31	ANTIPHAGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN C	WEAK ACTIVITY
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN C	ACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN C	WEAK ACTIVITY
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN C	INACTIVE
35	Not specified	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	RESPINOMYCIN D	None
36	CELL DIFFERENTIATION INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN D	ACTIVE
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	RESPINOMYCIN D	ACTIVE
38	ANTIMICROBIAL ACTIVITY(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN D	STRONG ACTIVITY
39	ANTIPHAGE ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RESPINOMYCIN D	ACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN D	ACTIVE
41	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN D	ACTIVE
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	RESPINOMYCIN D	INACTIVE

Citation 71290

Citation Details

Summary

Organisms and Their Experiments (1)

Streptomyces xanthocidicus (STREPTOMYCETACEAE)

Show SPARQL Queries (1)

Query 1